Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot crossover pharmacokinetic comparison of two Phargentis tiotropium dry powder inhalers versus Spiriva HandiHaler in healthy volunteers
NL-OMON44319Active, not recruiting
- Sponsor
- Phargentis SA
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of tiotropium in chronic obstructive pulmonary disease (COPD) (3 arms), sponsored by Phargentis SA. Primary endpoints: AUC0-t, AUC0-inf and 3 more. Started Aug 2017; status: active, not recruiting.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NL-OMON44319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44319.